SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-302802
Filing Date
2014-08-08
Accepted
2014-08-08 14:31:58
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d753499d10q.htm 10-Q 561593
2 EX-10.1 d753499dex101.htm EX-10.1 307834
3 EX-31.1 d753499dex311.htm EX-31.1 8402
4 EX-31.2 d753499dex312.htm EX-31.2 8430
5 EX-32.1 d753499dex321.htm EX-32.1 3343
6 EX-32.2 d753499dex322.htm EX-32.2 3413
  Complete submission text file 0001193125-14-302802.txt   3933379

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT drrx-20140630.xml EX-101.INS 521116
8 XBRL TAXONOMY EXTENSION SCHEMA drrx-20140630.xsd EX-101.SCH 31199
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drrx-20140630_cal.xml EX-101.CAL 58716
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20140630_def.xml EX-101.DEF 105546
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20140630_lab.xml EX-101.LAB 256433
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20140630_pre.xml EX-101.PRE 195501
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31615 | Film No.: 141027007
SIC: 2834 Pharmaceutical Preparations